Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor On Q2 2018 Results Earnings Call Transcript

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

Reference ID:

Source : https://seekingalpha.com/article/4220232-pernix-therapeutics-holdings-inc-ptx-ceo-john-sedor-q3-2018-results-earnings-call-transcript

Thank you for visit my website
Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor on Q3 2018 Results - Earnings Call Transcript
Pernix® Therapeutics Reports Third Quarter 2018 Financial Results
Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals
ETF Preview: Broad Market ETFs Decline, Consumer Sector in Focus on Earnings Misses, Merger News
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
Pernix Therapeutics Holdings, Inc. (PTX) CEO John Sedor on Q2 2018 Results - Earnings Call Transcript
Pernix Therapeutics Reports First Quarter 2018 Financial Results